American Riviera
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Amgen invests in precision oncology startup Syapse

By   /   Monday, November 20th, 2017  /   Comments Off on Amgen invests in precision oncology startup Syapse

    Print       Email
Amgen investment arm Amgen Ventures participated in a $30 million funding round for San Francisco precision oncology startup Syapse. The Thousand Oaks-based biotech giant joined several other investors, including Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Roche Venture Fund, Merck Global Health and others, Syapse announced Nov. 14. The Series D financing round will…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Our View: It’s time to take retail crime seriously

Read More →